ACMG is Awarded Five-Year, $13 Million Dollar Contract Renewal to Continue Important Efforts in Newborn Screening

BETHESDA, MD – October 5, 2018 | ACMG has been awarded a five-year extension of its NICHD contract...

2018 NBSTRN Network Meeting Presentations

Thank you to all for attending and participating in the 2018 NBSTRN Network Meeting, held July...

2018 NBSTRN Network Meeting Agenda

The 2018 NBSTRN Annual Network Meeting: Newborn Screening, Pilots, Genomics and Discoveries is held...

Our Mission

The Mission of the Newborn Screening Translational Research Network (NBSTRN) is to improve the health outcomes of newborns with genetic or congenital disorders by means of an infrastructure that allows investigators access to robust resources for newborn screening research.

Supported By

This project has been funded in whole or in part with Federal funds from the NICHD, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN275201800005C.

Funding Opportunities

Latest funding opportunities

Updated the first week of every month






Connecting ResearchersResources

to discover new technology, new treatments, and new diseases in newborn screening